MYO9B polymorphisms in patients with inflammatory bowel disease

od Núñez*, C, Oliver*, J, Mendoza, J L, Gómez‐García, M, Piñero, A, Taxonera, C, Díaz‐Rubio, M, López‐Nevot, M A, de la Concha, E G, Nieto, A, Urcelay, E, Martínez*, A, Martín*, J
Izdano 2007

Differential association of two PTPN22 coding variants with Crohn’s disease and ulcerative colitis

od Diaz-Gallo, L M, Espino-Paisán, L, Fransen, K, Gómez-García, M, van Sommeren, S, Cardeña, C, Rodrigo, L, Mendoza, J L, Taxonera, C, Nieto, A, Alcain, G, Cueto, I, López-Nevot, M A, Bottini, N, Barclay, M L, Crusius, J B, van Bodegraven, A A, Wijmenga, C, Ponsioen, C Y, Gearry, R B, Roberts, R L, Weersma, R K, Urcelay, E, Merriman, T R, Alizadeh, B Z, Martin, J
Izdano 2010

DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-con...

od Zabana Abdo, Y, Marín-Jiménez, I, Rodríguez-Lago, I, Vera, I, Martín, M D, Guerra, I, Gisbert, J P, Mesonero, F, Benítez, O, Taxonera, C, Ponferrada-Díaz, Á, Piqueras, M, Lucendo, A, Caballol, B, Mañosa, M, Martínez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Manceñido, N, Martínez-Pérez, T, López, A, Rodríguez, C, García-López, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, Barreiro-de Acosta, M, Arias, L, Barrio, J, Pérez, J L, Busquets, D, Pérez-Martínez, I, Navarro-Llavat, M, Hernández, V, Argüelles-Arias, F, Domènech, E, Esteve, M
izdano v J Crohns Colitis (2021)